Evidence map›Paper›PMID 25535285›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Both rejection and tolerance of allografts can occur in the absence of secondary lymphoid tissues.

Cavit D Kant, Yoshinobu Akiyama, Katsunori Tanaka, Susan Shea, Yohei Yamada, Sarah E Connolly, Jose Marino, Georges Tocco, Gilles Benichou

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cavit D KantTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Yoshinobu AkiyamaTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Katsunori TanakaTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Susan SheaTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Yohei YamadaTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Sarah E ConnollyTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Jose MarinoTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Georges ToccoTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Gilles BenichouTransplantation Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 gbenichou@partners.org.
Harvard University · USMassachusetts General Hospital · US

Funding

Tolerance to Composite Islet-Kidney Transplants in Non-Human PrimatesU19AI102405 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI COSIMI, A BENEDICT · 2012 to 2016
$7.7M
Effects of Lymphangiogenesis Blockade on Skin Allograft RejectionR21AI100278 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2012 to 2013
$370k
Tolerance induction to vascularized skin allograftsR03AI094235 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2011 to 2012
$167k
NIAID NIH HHS R03 AI094235NIAID NIH HHS R03AI094235NIAID NIH HHS R21 AI100278NIAID NIH HHS R21AI100278NIAID NIH HHS U19 AI102405
6 · The paper itself

Abstract

In this study, we showed that aly/aly mice, which are devoid of lymph nodes and Peyer's patches, acutely rejected fully allogeneic skin and heart grafts. They mounted potent inflammatory direct alloresponses but failed to develop indirect alloreactivity after transplantation. Remarkably, skin allografts also were rejected acutely by splenectomized aly/aly (aly/aly-spl(-)) mice devoid of all secondary lymphoid organs. In these recipients, the rejection was mediated by alloreactive CD8(+) T cells presumably primed in the bone marrow. In contrast, cardiac transplants were not rejected by aly/aly-spl(-) mice. Actually, aly/aly-spl(-) mice that spontaneously accepted a heart allotransplant and displayed donor-specific tolerance also accepted skin grafts from the same, but not a third-party, donor via a mechanism involving CD4(+) regulatory T cells producing IL-10 cytokine. Therefore, direct priming of alloreactive T cells, as well as rejection and regulatory tolerance of allogeneic transplants, can occur in recipient mice lacking secondary lymphoid organs.

Indexed as

Immune ToleranceAllograftsAnimalsBone Marrow TransplantationGraft RejectionHeart TransplantationImmunologic MemoryLymphoid TissueMiceMice, KnockoutSkin TransplantationT-Lymphocyte Subsets

Identifiers

PMID25535285
PMCPMC4297718
OpenAlexW1631097116

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.